FHL2, a novel tissue-specific coactivator of the androgen receptor

Citation
Jm. Muller et al., FHL2, a novel tissue-specific coactivator of the androgen receptor, EMBO J, 19(3), 2000, pp. 359-369
Citations number
59
Categorie Soggetti
Molecular Biology & Genetics
Journal title
EMBO JOURNAL
ISSN journal
02614189 → ACNP
Volume
19
Issue
3
Year of publication
2000
Pages
359 - 369
Database
ISI
SICI code
0261-4189(20000201)19:3<359:FANTCO>2.0.ZU;2-8
Abstract
The control of target gene expression by nuclear receptors requires the rec ruitment of multiple cofactors, However, the exact mechanisms by which nucl ear receptor-cofactor interactions result in tissue-specific gene regulatio n are unclear Here we characterize a novel tissue-specific coactivator for the androgen receptor (AR), which is identical to a previously reported pro tein FHL2/DRAL with unknown function. In the adult, FHL2 is expressed in th e myocardium of the heart and in the epithelial cells of the prostate, wher e it colocalizes with the AR in the nucleus. FHL2 contains a strong, autono mous transactivation function and binds specifically to the AR in vitro and in vivo. In an agonist- and AF-2-dependent manner FHL2 selectively increas es the transcriptional activity of the AR, but not that of any other nuclea r receptor. In addition, the transcription of the prostate-specific AR targ et gene probasin is coactivated by FHL2, Taken together, our data demonstra te that FHL2 is the first LIM-only coactivator of the AR with a unique tiss ue-specific expression pattern.